NCT07139080Completed
Effect of Mobile Application-Based Education on Self-Efficacy, Medication Adherence and Sleep Quality in Asthma.
The Effect of Mobile Application-Based Education on Self-Efficacy, Medication Adherence and Sleep Quality in Asthma Patients.
Source: ClinicalTrials.gov · Last updated 24 Aug 2025
Brief summary (registry, in English)
Asthma patients with recurrent airway obstruction frequently exhibit poor symptom control, characterized by treatment non-adherence and sleep-wake cycle disturbances. A nurse-led mobile health education intervention may address these challenges by enhancing collaborative disease management, enabling remote patient monitoring, and strengthening self-management competencies. The AstımAsistan application was designed to monitor changes in patient self-efficacy, medication adherence, and sleep quality through three core features: (1) patient education modules, (2) breathing exercise/medication reminders, and (3) mobile consultation capabilities. Study data were collected using four instruments: (1) the Participant Information Form, (2) the Chronic Disease Self-Efficacy Scale, (3) the Medication Adherence Reporting Scale, and (4) the Pittsburgh Sleep Quality Index. The mobile education-based application was developed following the ADDIE (Analysis, Design, Development, Implementation, and Evaluation) instructional design model."
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 68 (actual)
- First submitted
- 8 May 2025
- Start date
- 1 Dec 2023
- Primary completion date
- 28 Apr 2025
- Lead sponsor
- Gulhane Training and Research Hospital
- Diseases
- Asthma
- NCT number
- NCT07139080
What you commit to
- Study type: Interventional
- Participants enrolled: 68
- From 1 Dec 2023 to the primary completion date, 28 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Being on psychoactive or opioid therapy
Other illness
- Being diagnosed with a psychiatric disease
- Being diagnosed with a sleep disorder related to non-respiratory reasons (physical and psychological) and being treated
Other
- Being hospitalized for asthma treatment
- Having a language barrier that hinders communication
- Being diagnosed with COPD
- Intervention group;
- The participant was diagnosed with a health problem requiring inpatient treatment during the study period.
- The participant withdraws from the study voluntarily.
- Inability to use the mobile application during the research
- Reading fewer than 6 theme headings in the mobile application (75% or less) and missing breathing exercises for more than 16 days (80% or less)
- Control group;
- The participant was diagnosed with a health problem requiring inpatient treatment during the study period.
- The participant withdraws from the study voluntarily.
Who the study is looking for
- Being between the ages of 18-65
- Having been diagnosed with asthma at least 6 months ago
- Being treated for asthma in oral, inhaler or injection forms
- Being literate in Turkish
- Having an Android phone on which the mobile application can be installed and being able to use the phone
- Having mobile network or wireless internet access
- Volunteering to participate in research
- Living in Ankara
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gulhane Training and Research Hospital Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.